Abstract

Kava, a non-alcoholic beverage derived from the Piper methysticum plant, commonly also known as Kava, has a prominent role in the cultures of Oceania due to its calming and soothing effects. These psychoactive properties have sparked interest beyond Oceania and in the scientific community, who see potential for medicinal applications. However, alongside these beneficial effects, consumption of Kava has been linked to potential hepatotoxicity, raising safety concerns. Understanding the cause of this hepatotoxicity requires a detailed exploration of Kava's metabolic processes, specifically those involving kavain, its primary constituent. Recent studies have found the hydroxylation of kavain to 12-hydroxykavain as a key step in Kava's metabolic pathway. Yet, the precise mechanism of this conversion and the hydroxylation intermediates involved remain poorly understood. To address this knowledge gap, our study employed Spartan, a computational chemistry software, to model the hydroxylation process. We analyzed the stability and chemical properties of the proposed reaction intermediates, providing a detailed view of this critical phase of metabolism. Our analysis reveals that three of the five proposed intermediates appear stable, suggesting they may play significant roles in the hydroxylation process. This finding also enabled us to narrow down the possible reaction pathways of hydroxylation. Having a better understanding of the key step of Kava metabolism could guide the development of safer, more effective Kava-based products, balancing the therapeutic potential of Kava with a reduced risk profile.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call